High prevalence of HTLV-I infection in Mashhad, Northeast Iran: A population-based seroepidemiology survey

Journal of Clinical Virology

Volumn 52, Issue 3, 2011, Pages 172-176

  Rafatpanah, Houshang ^a,b   Hedayati Moghaddam, Mohammad Reza ^a   Fathimoghadam, Farhad ^a   Bidkhori, Hamid Reza ^a   Shamsian, Seyed Khosro ^a   Ahmadi, Sanaz ^a   Sohgandi, Leila ^a   Azarpazhooh, Mahmoud Reza ^a,c   Rezaee, Seyed Abdolrahim ^a,b   Farid, Reza ^a,b   Bazarbachi, Ali ^d  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

General population; HTLV I infection; Iran; Mashhad; Risk factors; Seroepidemiology

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CHILD; CROSS-SECTIONAL STUDY; EDUCATIONAL STATUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; HUMAN TISSUE; INFECTION RATE; IRAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL HISTORY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SEROEPIDEMIOLOGY; TRADITIONAL MEDICINE; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DELTARETROVIRUS ANTIBODIES; FEMALE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFANT; IRAN; MALE; MIDDLE AGED; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES; SOCIAL CLASS;

EID: 80054701931     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.07.004     Document Type: Article

References (31)

1. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985, 2:407-410.
2. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K.I., et al. Adult T-cell leukaemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981, 78:6476-6480.
3. de The G., Kazanji M. An HTLV-I/II vaccine: from animal models to clinical trials?. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(Suppl 1):S191-S198.
4. Pawson R., Mufti G.J., Pagliuca A. Management of adult T-cell leukaemia/lymphoma. Br J Haematol 1998, 100:453-458.
5. Rezvan H., Ahmadi J., Farhadi M. A cluster of HTLV-I infection in northeastern of Iran. Transfusion Today 1996, 27:8-9.
6. Safai B., Huang J.L., Boeri E., Farid R., Raafat J., Schutzer P., et al. Prevalence of HTLV type I infection in Iran: a serological and genetic study. AIDS Res Hum Retroviruses 1996, 12:1185-1190.
7. Statistical Centre of Iran. Population estimation by urban and rural areas, 2006. Available at: [accessed June 10, 2010]. http://www.sci.org.ir/englishold/Sel/j_shvro_84.htm.
8. Kajiyama W., Kashiwagi S., Ikematsu H., Hayashi J., Nomura H., Okochi K. Intrafamilial transmission of adult T cell leukemia virus. J Infect Dis 1986, 154:851-857.
9. Murphy E.L., Figueroa J.P., Gibbs W.N., Holding-Cobham M., Cranston B., Malley K., et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants. Am J Epidemiol 1991, 133:1114-1124.
10. Mueller N., Okayama A., Stuver S., Tachibana N. Findings from the Miyazaki Cohort Study. J Acquir Immune Defic Syndr Hum Retrovirol 1996, 13(Suppl 1):S2-S7.
11. Murphy E.L., Watanabe K., Nass C.C., Ownby H., Williams A., Nemo G. Evidence among blood donors for a 30-year old epidemic of HTLV-II infection in the United States. J Infect Dis 1999, 180:1777-1783.
12. Schreiber G.B., Murphy E.L., Horton J.A., Wright D.J., Garfein R., Chien H.C., et al. Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: the Retrovirus Epidemiology Donor Study. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:263-271.
13. Manns A., Hisada M., La Grenade L. Human T-lymphotropic virus type I infection. Lancet 1999, 353:1951-1958.
14. Catalan-Soares B.C., Carneiro-Proietti A.B.F., Proietti F.A. HTLV-I/II and blood donors: determinants associated with seropositivity in a low risk population. Rev Saude Publica 2003, 37:470-476.
15. Sanchez-Palacios C., Gotuzzo E., Vandamme A.M., Maldonado Y. Seroprevalence and risk factors for human T-cell lymphotropic virus (HTLV-I) infection among ethnically and geographically diverse Peruvian women. Int J Infect Dis 2003, 7:132-137.
16. Miller G.J., Pegram S.M., Kirkwood B.R., Beckles G.L., Byam N.T., Clayden S.A., et al. Ethnic composition, age and sex, together with location and standard of housing as determinants of HLTV-I infection in an urban Trinidadian community. Int J Cancer 1986, 38:801-808.
17. Maloney E.M., Murphy E.L., Figueroa J.P., Gibbs W.N., Cranston B., Hanchard B., et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. II. Geographic and ecologic determinants. Am J Epidemiol 1991, 133:1125-1134.
18. Tarhini M., Kchour G., Sayadpour Zanjani D., Rafatpanah H., Otrock Z.K., Bazarbachi A., et al. Declining tendency of human T-cell leukaemia virus type I carrier rates among blood donors in Mashhad, Iran. Pathology 2009, 41:498-499.
19. Fathi Moghaddam F., Hedayati-Moghaddam M.R., Bidkhori H.R., Ahmadi S., Sima H.R. The prevalence of Hepatitis B antigen-positivity in the general population of Mashhad. Iran Hepat Mon 2011, 11(5):346-350.
20. Biggar R.J., Johnson B.K., Oster C., Sarin P.S., Ocheng D., Tukei P., et al. Regional variation in prevalence of antibody against human T-lymphotropic virus types I and III in Kenya, East Africa. Int J Cancer 1985, 35:763-767.
21. Wiktor S.Z., Piot P., Mann J.M., Nzilambi N., Francis H., Vercauteren G., et al. Human T cell lymphotropic virus type I (HTLV-I) among female prostitutes in Kinshasa. Zaire J Infect Dis 1990, 161:1073-1077.
22. Kondo T., Kono H., Miyamoto N., Yoshida R., Toki H., Matsumoto I., et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int J Cancer 1989, 43:1061-1064.
23. Takezaki T., Tajima K., Komoda H., Imai J. Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. J Infect Dis 1995, 171:559-565.
24. Dourado I., Alcantara L.C., Barreto M.L., da Gloria Teixeira M., Galvão-Castro B. HTLV-I in the general population of Salvador, Brazil: a city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr 2003, 34:527-531.
25. Armah H.B., Narter-Olaga E.G., Adjei A.A., Asomaning K., Gyasi R.K., Tettey Y. Seroprevalence of human T-cell lymphotropic virus type I among pregnant women in Accra, Ghana. J Med Microbiol 2006, 55:765-770.
26. Kazanji M., Gessain A. Human T-cell Lymphotropic Virus types I and II (HTLV-I/II) in French Guiana: clinical and molecular epidemiology. Cad Saude Publica 2003, 19:1227-1240.
27. Rouet F., Foucher C., Rabier M., Gawronski I., Taverne D., Chancerel B., et al. Human T-lymphotropic virus type I among blood donors from Guadeloupe: donation, demographic, and biologic characteristics. Transfusion 1999, 39:639-644.
28. Plancoulaine S., Buigues R.P., Murphy E.L., van Beveren M., Pouliquen J.F., Joubert M., et al. Demographic and familial characteristics of HTLV-1 infection among an isolated, highly endemic population of African origin in French Guiana. Int J Cancer 1998, 76:331-336.
29. Maloney E.M., Ramirez H., Levin A., Blattner W.A. A survey of the human T-cell lymphotropic virus type I (HTLV-I) in south-western Colombia. Int J Cancer 1989, 44:419-423.
30. Edlich R.F., Arnette J.A., Williams F.M. Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med 2000, 18:109-119.
31. Rouet F., Herrmann-Storck C., Courouble G., Deloumeaux J., Madani D., Strobel M. A case-control study of risk factors associated with human T-cell lymphotrophic virus type-I seropositivity in blood donors from Guadeloupe, French West Indies. Vox Sang 2002, 82:61-66.